News

Ondine Biopharma, a biotechnology company, has entered into a non-binding letter of intent with JS Dental Technologies, a Toronto-based firm to purchase the company’s dental healthcare business. Subject

Arbor Vita, a biopharmaceutical company, has received 510(k) clearance from the FDA for its AVantage A/H5N1 flu test. According to Arbor Vita, AVantage flu test is a non-invasive

Eric Poma, CEO of Molecular Templates, said: “Cancer therapeutics is a crowded and competitive field. Molecular Templates’s platform technology is compelling because it allows us to rapidly screen

Maynard Howe, vice chairman and CEO of Stemedica, said: “Stemedica is executing a dual-path strategy in which the Stemedica USA facility will continue to manufacture current good manufacturing

According to SenoRx, this new version of the device incorporates a microminiaturization ultrasound technology that combines personal computing power and flexibility. The new ultrasound component is designed, developed

Dr Caggiano will continue to manage the preclinical and R&D departments, as well as oversee Acorda’s preclinical programs that aim to develop novel approaches to the treatment of

The series B financing included participation from all of Marinus’s existing investors, including Canaan Partners, Domain Associates, Sofinnova Ventures and Foundation Medical Partners. The funding will advance the

Medtronic has also recently acquired Ventor Technologies, a developer of percutaneous, catheter-based transapical aortic valve replacement products. Bill Hawkins, chairman and CEO of Medtronic, said: “These acquisitions position

Lanthanum carbonate tablets are used in cases of kidney failure and would facilitate phosphate absorption. Lanthanum carbonate tablets are sold under the brand name of Fosrenol by the